SCHEMBL6722528

SCHEMBL6722528

O=C(NCCOc1ccc(CC(Nc2ccccc2)C(=O)O)cc1)c1ccc(-c2ccccc2)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.57
NPC1 O15118 9/20 0.54
RAB9A P51151 8/20 0.54
SMN1; SMN2 Q16637 4/20 0.54
HPGD P15428 1/20 0.54
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
ITGB3 P05106 1/20 0.51
ITGA2B P08514 1/20 0.51
POLB P06746 1/20 0.50
CASP3 P42574 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
MAPT P10636 1/20 0.48
NFKB1 P19838 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
PPARD Q03181 1/20 0.48
PPARA Q07869 1/20 0.48
ITGB1 P05556 1/20 0.46
ITGA5 P08648 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6722548 0.90 PPARG (0.52) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6716452 0.89 NPC1 (0.50) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6722086 0.86 NPC1 (0.53) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6722571 0.85 PPARG (0.58) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6714967 0.83 PPARG (0.65) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6722579 0.81 PPARG (0.54) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6722575 0.81 PPARG (0.47) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6716114 0.80 NPC1 (0.51) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6714896 0.79 PPARG (0.60) PPARGNPC1RAB9ASMN1; SMN2HPGD
SCHEMBL6933519 0.79 PPARG (0.53) PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040006141-A1 Amidocarboxylic acid compounds SANKYO COMPANY, LTD (JP) 2004-01-08 US disclosed
US-6528525-B1 Amidocarboxylic acid derivatives SANKYO COMPANY, LIMITED (JP) 2003-03-04 US disclosed
EP-1026149-A1 AMIDOCARBOXYLIC ACID DERIVATIVES Sankyo Company Limited (JP) 2000-08-09 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040006141-A1 Amidocarboxylic acid compounds NR1H2, AGK, APOL1 PPARG 23/4885NPC1 812/4885RAB9A 3140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.